Longeveron Inc. (LGVN)
NASDAQ (CM) NASDAQ (CM) Primary 
Why has Longeveron stock tripled in two days?
Longeveron Inc (NASDAQ: LGVN) rallied another 50% on Thursday as investors continued to celebrate the positive update of its Lomecel-B study. Why is it significant for Longeveron stock?
Why Is Longeveron (LGVN) Stock Up 46% Today?
Longeveron (NASDAQ: LGVN ) stock continues to rally on Thursday as investors celebrate positive trial news from the clinical-stage biotechnology company. The big news that boosted shares of LGVN stock higher was investigator data from a Phase 2 trial of Lomocel-B.
Why Is Longeveron (LGVN) Stock Up 120% Today?
The clinical-stage biotech market is as vast as it is complicated. Companies operating in this space are wide-ranging in the illnesses they look to treat.
Longeveron Inc. (LGVN) Q1 2024 Earnings Call Transcript
Longeveron Inc. (NASDAQ:LGVN ) Q1 2024 Earnings Conference Call May 14, 2024 5:00 PM ET Company Participants Derek Cole - IR, Advisory Solutions Wa'el Hashad - CEO Nataliya Agafonova - Chief Medical Officer Lisa Locklear - CFO Joshua Hare - Co-Founder, Chief Science Officer and Chairman of the Board Conference Call Participants Ram Selvaraju - H.C. Wainwright Operator Good day, ladies and gentlemen, and welcome to Longeveron 2024 First Quarter Financial Results Earnings Call.
